ArticleEmerging infectious diseases2006
KPC type beta-lactamase, rural Pennsylvania.
Article in Emerging infectious diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.The Lancet. Infectious diseases · 2013Review
- Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria.Antimicrobial agents and chemotherapy · 2012Article
- Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.Infection control and hospital epidemiology · 2009Article
- Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.Antimicrobial agents and chemotherapy · 2009Article
- Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.The Journal of antimicrobial chemotherapy · 2009Article
- Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid.Journal of clinical microbiology · 2008Article
- Crystal structure of KPC-2: insights into carbapenemase activity in class A beta-lactamases.Biochemistry · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.